UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

|X| Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange
    Act Of 1934

                      For the quarterly period ended December 31, 2014

| | Transition Report Under Section 13 or 15(d) of the Securities Exchange Act
    Of 1934

             For the transition period from __________ to __________

                        Commission File Number: 000-54231

                                 AMERICANN, INC
               -------------------------------------------------
             (Exact name of registrant as specified in its charter)

             DELAWARE                                   27-4336843
   -------------------------------            -------------------------------
 (State or other jurisdiction of            (I.R.S. Employer Identification No.)
  incorporation or organization)

                          3200 Brighton Blvd. Unit 114
                                Denver, CO 80216
              ---------------------------------------------------
          (Address of principal executive offices, including Zip Code)

                                 (303) 862-9000
                       -----------------------------------
                (Issuer's telephone number, including area code)

                  ---------------------------------------------
          (Former name or former address if changed since last report)

Check  whether the issuer (1) filed all reports  required to be filed by section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted  electronically  and
posted on its corporate Web site, if any, every  Interactive  Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter)  during the  preceding 12 months (or for such shorter  period that
the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a small reporting  company.  See
the   definitions   of   "large   accelerated   filer,"   "accelerated   filer,"
"non-accelerated  filer," and "smaller  reporting  company" in Rule 12b-2 of the
Exchange Act.

Large accelerated filer [ ]                Accelerated filer          [ ]
Non-accelerated filer   [ ]                Smaller reporting company  [X]

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [x]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: 16,684,334 common stock as of January
31, 2015.

                                       1
<PAGE>

 Americann, Inc.
 (fka Nevada Health Scan, Inc.)
 Condensed Balance Sheet

                                             Unaudited
                                          December 31, 2014   September 30, 2014
ASSETS
Current Assets:
Cash                                             $73,269        $   173,956

Deposits                                         100,000            100,000

Interest receivable                               16,908                  -


Prepaid expenses                                  11,953              5,000
                                              ----------            -------
Total Current Assets                             202,130            278,956
                                              ----------            -------

Plant, property, and equipment:

Furniture and equipment (net of $615
   and $394- depreciation)                         7,242               7,463

Land                                           2,250,809           2,250,809
                                              ----------           ---------


Total property, plant and equipment            2,258,051           2,258,272
                                              ----------           ---------
Other assets:
   Notes receivable                              965,000           1,000,000

   Security deposit                                3,110               3,110
                                              ----------          ----------

  Total other assets                             968,110           1,003,110
                                              ----------          ----------
TOTAL ASSETS                                  $3,428,291          $3,540,338
                                              ==========          ==========

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Accounts payable                               $  10,134           $  25,515


Related party payables                            43,220              16,357
Interest payable - related
party                                             15,053               5,192

Other payables                                    38,810              12,981

Deferred revenue                                   1,740             11,7400
                                                 -------             -------

Total current liabilities                        108,957              71,785
                                                 -------             -------
Long-term liabilities - note payable related
party                                            805,000             825,000
                                                 -------             -------
TOTAL LIABILITIES                                913,957             896,785
                                                 -------             -------

                                       2
<PAGE>

 Americann, Inc.
 (fka Nevada Health Scan, Inc.)
 Condensed Balance Sheet (Continued)



SHAREHOLDERS' EQUITY

 Preferred stock, $0.0001 par value per share;
  Authorized 20,000,000 Shares; Issued
       and outstanding -0- shares.                   --                   --

 Common Stock, $0.0001 per share;
  Authorized 100,000,000 Shares; Issued and
    outstanding 16,581,000 and 16,581,000 at
    December 31, 2014 and September 30, 2014,
    Respectively                                  1,658                1,658
 Capital paid in excess of par value          4,829,578            4,716,794

 Accumulated (Deficit)                       (2,316,902)          (2,074,899)
                                            ------------         -----------

 TOTAL SHAREHOLDERS' EQUITY                   2,514,334            2,643,553
                                              ---------           ----------

 TOTAL LIABILITIES AND SHAREHOLDERS'
    EQUITY                                   $3,428,291           $3,540,338
                                             ==========           ==========

    See Accompanying Notes To These Unaudited Condensed Financial Statements.

                                       3
<PAGE>

Americann, Inc.
(fka Nevada Health Scan, Inc.)
Condensed Statement Of Operations

                                              Three               Three
                                           Months Ended       Months Ended
                                        December 31, 2014   December 31, 2013

 Revenue:                                $    30,000               $      -
                                         -----------               --------
 General & Administrative Expenses
 Accounting                                   10,000                  4,900
 Advertising                                  2,875
 Contract and consulting                      63,184                      -
 Depreciation                                    221
 Other G & A                                  45,429                    200
 Legal                                        18,380                      -
 Rent                                         8,310
 Salaries                                    30,518
 Stock based compensation                   112,784
 Stock Transfer Fee                              677                    600
 Taxes                                         9,464
 Travel                                        5,505                      -
                                         -----------            -----------

 Total G & A                                 307,347                  5,700
                                         -----------            -----------

 (Loss) from operations                     (277,347)                (5,700)
                                         -----------            -----------

 Other income (expense)
 Interest expense - related party             (9,862)
 Interest income                              45,206                      -
                                         -----------            -----------
 Total other income                           35,344
                                         -----------
 Net (loss)                              $  (242,003)           $    (5,700)
                                         ===========            ===========

 Basic and diluted (Loss) per
  common share                               $ (0.02)                $ 0.00
                                         ===========            ===========

 Weighted Average Common Shares
  Outstanding                             16,581,000             16,100,000
                                          ==========             ==========

    See Accompanying Notes To These Unaudited Condensed Financial Statements.

                                       4
<PAGE>

Americann, Inc.
(fka Nevada Health Scan, Inc.)
Statement Of Cash Flows

<TABLE>
<S>                                                  <C>                  <C>

                                                    Three               Three
                                                Months Ended        Months Ended
                                              December 31, 2014  December 31, 2013
Cash Flows From Operating Activities:
Net (Loss)                                         $   (242,003)    $    (5,700)
Adjustments to reconcile net loss to net
cash used in
 operating activities:

Depreciation                                                221              -

Stock based compensation and option expense             112,784              -

Increase in interest
receivable                                             (16,908)              -

Increase in deposit and prepaid expenses                (6,953)              -
Increase in accounts payable and
related party                                           11,482

Increase in interest payable                             9,861

Increase in other payables                              25,829

(Decrease) in deferred revenue                         (10,000)            200
                                                      --------            ---

Net Cash Flows (used) in
operations                                            (115,687)         (5,500)
                                                     ---------         -------
Cash Flows From Investing Activities:
Net Cash Flows (used) in Investing
activities
Payment received on note receivable:                    35,000               -
                                                       -------               -
Cash Flows From Financing Activities:                   35,000

Payment to related party                               (50,000)              -
Proceed from related party debt                         30,000           5,500
                                                       -------           -----
Net Cash Flows provided by financing activities        (20,000)          5,500
                                                      --------           -----
Net Increase (Decrease) In Cash and cash
equivalents                                           (100,687)              0
Cash and cash equivalents at beginning of period       173,956               -
                                                      --------          ------
Cash and cash equivalents at end of period            $ 73,269          $    0
                                                      ========          ======

Supplementary Disclosure Of Cash Flow
Information:


Cash paid for interest                                  $    -          $    -
                                                        ======          ======
Cash paid for income taxes                              $    -          $    -
                                                        ======          ======
Expenses paid on behalf of Company                    $ 37,720               -
                                                      ========          ======
</TABLE>


    See Accompanying Notes To These Unaudited Condensed Financial Statements.

                                       5
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 1.    DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

Americann,  Inc. (fka Nevada Health Scan,  Inc.) ("the Company" or "the Issuer")
was  organized  under the laws of the State of  Delaware on June 25,  2010.  The
Company was established as part of the Chapter 11 reorganization of AP Corporate
Services,  Inc. ("AP").  Under AP's Plan of Reorganization,  as confirmed by the
U.S.  Bankruptcy Court for the Central  District of California,  the Company was
incorporated  to:  (1)  receive  and  own  any  interest  which  AP  had  in the
development  of an MRI  scanning  facility;  and (2) issue  shares of its common
stock to AP's general unsecured creditors, to its administrative  creditors, and
to its shareholders.

Since the Company lacked the resources to  effectively  develop an MRI facility,
in June 2012 the  Company  decided  to  promote  medical  tourism  by  providing
information  on a website  for those  seeking to travel  abroad  for  healthcare
services.  The Company  planned to generate  revenue by selling  advertising  to
healthcare   providers  and  related  businesses  including  hotels  and  travel
agencies.

In September 2013, the Company abandoned its business plan relating to promoting
medical tourism.

On January 17,  2014,  a  privately  held  limited  liability  company  acquired
approximately  93% of the  Company's  outstanding  shares of common  stock  from
several of the Company's  shareholders  which resulted in a change in control of
the Company.

The Company's new business plan is to offer a comprehensive,  turnkey package of
services  that  includes  consulting,  design,  construction  and  financing  to
approved and licensed  marijuana  operators  throughout the United  States.  The
Company's  business  plan is based on the  anticipated  growth of the  regulated
marijuana market in the United States.

The Company's  activities  are subject to  significant  risks and  uncertainties
including failure to secure funding to properly grow the operations.

Basis of Presentation

The following (a)  condensed  balance sheet as of September 30, 2014,  which has
been derived from audited financial statements,  and (b) the unaudited condensed
financial  statements  as of December 31, 2014 and 2013,  have been  prepared in
accordance with accounting principles generally accepted in the United States of
America and the rules of the Securities  and Exchange  Commission  ("SEC"),  and
should be read in conjunction  with the audited  financial  statements and notes
thereto  contained in the Company's Form 10-K filed with the SEC on February 18,
2015.  In the  opinion of  management,  all  adjustments,  consisting  of normal
recurring  adjustments,  necessary for a fair presentation of financial position
and the results of operations for the interim

                                       6
<PAGE>



                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 1.    DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING
           POLICIES (Continued)

periods  presented  have been  reflected  herein.  The results of operations for
interim periods are not necessarily indicative of the results to be expected for
future  quarters  or  for  the  full  year.  Notes  to the  condensed  financial
statements which substantially duplicate the disclosure contained in the audited
financial  statements  for fiscal  2014 as  reported  in the Form 10-K have been
omitted.

Summary of Significant Accounting Policies

This  summary of  significant  accounting  policies is  presented  to assist the
reader in understanding and evaluating the Company's financial  statements.  The
condensed consolidated financial statements and notes are representations of the
Company's management,  which is responsible for their integrity and objectivity.
These accounting  policies conform to generally accepted  accounting  principles
and  have  been  consistently  applied  in  the  preparation  of  the  financial
statements.

    a. USE OF ESTIMATES

The  preparation  of financial  statements  in  conformity  with U.S.  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that  affect the  reported  amounts of assets and  liabilities  and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting  period.  The  more  significant  estimates  and  assumptions  made by
management  are valuation of equity  instruments,  depreciation  of property and
equipment,  and deferred tax asset  valuation.  Actual results could differ from
those estimates as the current economic  environment has increased the degree of
uncertainty inherent in these estimates and assumptions.

    b. CASH AND CASH EQUIVALENTS

For  the  balance  sheet  and  statements  of  cash  flows,  all  highly  liquid
investments  with  maturity  of 90  days  or  less  are  considered  to be  cash
equivalents.  The Company had a cash balance of $73,269 as of December 31, 2014.
At times, such cash balances may be in excess of the FDIC limit of $250,000

                                       7
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

    c. PROPERTY AND EQUIPMENT

LONG-LIVED ASSETS

The  Company's  long-lived  assets  consisted of property and  equipment and are
reviewed for  impairment in  accordance  with the guidance of the FASB Topic ASC
360,  Property,  Plant, and Equipment,  and FASB ASC Topic 205,  Presentation of
Financial  Statements.  The Company  tests for  impairment  losses on long-lived
assets used in operations  whenever events or changes in circumstances  indicate
that the carrying amount of the asset may not be recoverable.  Recoverability of
an asset to be held and used is measured by a comparison of the carrying  amount
of an asset to the future  undiscounted  cash flows  expected to be generated by
the asset.  If such asset is  considered  to be impaired,  the  impairment to be
recognized  is measured by the amount by which the carrying  amount of the asset
exceeds its fair value. Impairment evaluations involve management's estimates on
asset  useful  lives and future cash flows.  Actual  useful lives and cash flows
could be  different  from  those  estimated  by  management  which  could have a
material effect on our reporting results and financial positions.  Fair value is
determined through various valuation  techniques  including discounted cash flow
models,  quoted  market  values  and  third-party  independent  appraisals,   as
considered necessary. Through December 31, 2014, the Company had not experienced
impairment losses on its long-lived assets.  However, there can be no assurances
that demand for the Company's  products or services will  continue,  which could
result in an impairment of long-lived assets in the future.

            Office furniture and equipment 7 years

    d. RELATED PARTIES

A party is  considered  to be related to the  Company if the party  directly  or
indirectly or through one or more intermediaries, controls, is controlled by, or
is under common control with the Company. Related parties also include principal
owners of the Company,  its  management,  members of the  immediate  families of
principal  owners of the Company and its management and other parties with which
the Company may deal if one party  controls or can  significantly  influence the
management  or  operating  policies  of the other to an  extent  that one of the
transacting  parties  might be  prevented  from fully  pursuing its own separate
interests. A party which can significantly influence the management or operating
policies of the transacting parties or if it has an ownership interest in one of
the transacting  parties and can significantly  influence the other to an extent
that one or more of the  transacting  parties  might  be  prevented  from  fully
pursuing its own separate interests is also a related party.

                                       8
<PAGE>

                                      AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
                      Notes To Unaudited Condensed Financial Statements For the
                three month period ended December 31, 2014 and 2013

    e. EQUITY INSTRUMENTS ISSUED TO NON-EMPLOYEES FOR ACQUIRING GOODS OR
       SERVICES

Issuances  of the  Company's  common stock or warrants  for  acquiring  goods or
services  are  measured at the fair value of the  consideration  received or the
fair  value  of the  equity  instruments  issued,  whichever  is  more  reliably
measurable.  The measurement  date for the fair value of the equity  instruments
issued to consultants or vendors is determined at the earlier of (i) the date at
which a commitment for performance to earn the equity  instruments is reached (a
"performance  commitment"  which would  include a penalty  considered to be of a
magnitude that is a sufficiently large disincentive for  nonperformance) or (ii)
the  date at which  performance  is  complete.  When it is  appropriate  for the
Company  to  recognize  the cost of a  transaction  during  financial  reporting
periods prior to the  measurement  date,  for purposes of  recognition  of costs
during those periods, the equity instrument is measured at the then-current fair
values at each of those interim  financial  reporting dates. As a result,  stock
options  granted to consultants  are measured at the then current fair values at
each reporting date.

    f. REVENUE RECOGNITION

The  Company  recognizes  revenue  on  consulting  at the  time the  service  is
rendered.

    g. ADVERTISING

Advertising,  promotional and selling expenses  consisted of sales and marketing
expenses,  and  promotional  activity  expenses.  Expenses are  recognized  when
incurred.

    h. LOSS PER SHARE

The Company  computes net loss per share in accordance  with the FASB Accounting
Standards Codification ("ASC"). The ASC specifies the computation,  presentation
and disclosure  requirements  for loss per share for entities with publicly held
common stock.

Basic  loss per  share  amounts  is  computed  by  dividing  the net loss by the
weighted  average number of common shares  outstanding.  The equity  instruments
such  as  warrants  and  options  were  not  included  in  the  loss  per  share
calculations because the inclusion would have been anti-dilutive.

    i. CONCENTRATION OF CREDIT RISKS

Financial  instruments that potentially subject the Company to concentrations of
credit risk  consist  principally  of cash,  notes  receivables,  deposits,  and
prepaid expenses. The Company places its cash with high credit quality financial
institutions. As of December 31, 2014 there were no trade receivables.

                                       9
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 2.    GOING CONCERN

The accompanying  financial  statements have been prepared  assuming the Company
will continue as a going concern,  which  contemplates,  among other things, the
realization  of assets and  satisfaction  of liabilities in the normal course of
business. The Company had an accumulated deficit of approximately $2,317,000 and
$2,075,000 at December 31, 2014 and September 30, 2014, respectively,  had a net
loss of  approximately,  $242,000  for the period ended  December 31, 2014,  and
working capital of  approximately  $93,000 at December 31, 2014.  These matters,
among others,  raise  substantial doubt about our ability to continue as a going
concern.  While the Company is  attempting to increase  operations  and generate
additional  revenues,  the Company's cash position may not be significant enough
to  support  the  Company's  daily  operations.   Management  intends  to  raise
additional funds by way of a public offering.

Management  believes that the actions presently being taken to further implement
its business plan and generate  additional  revenues provide the opportunity for
the Company to continue as a going  concern.  While the Company  believes in the
viability of its strategy to generate  additional revenues and in its ability to
raise additional funds,  there can be no assurances to that effect.  The ability
of the Company to continue as a going  concern is dependent  upon the  Company's
ability to further implement its business plan and generate additional revenues.

The financial  statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern.

NOTE 3.    NOTES RECEIVABLE

On June 23, 2014 the Company  entered into a secured  financing  agreement  with
Nature's Own Wellness Center, Inc. ("Nature's Own"). Financing was provided in a
series of tranches for the  construction  progresses to renovate a 15,000 square
foot warehouse into a cannabis growing and processing facility. The total amount
of financing was $1,000,000,  and accrues interest at 18% per annum, and matures
on November 1, 2016.  Monthly  interest  only payments are of $15,000 due July 1
through  December  31,  2014.   Monthly   principal  and  interest  payments  of
approximately  $50,000  begin on December  1, 2014  through  maturity.  The note
receivable is  collaterized by  substantially  all of the assets of Nature's Own
and is personally guaranteed by one of the majority owners of Nature's Own.

Nature's Own is a licensed  Colorado  cannabis  dispensary owner and grower with
separate and distinct  operations.  Nature's Own has its own revenue  generating
activities and is not  financially  dependent upon the Company.  The Company has
not  guaranteed  any debtor or  obligation  of Nature's  Own. The Company has no
control  of  Nature's  Own  operations  and  does  not  perform  any  management
functions. However, a majority shareholder of Nature's Own owns 100,000

                                       10
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 3.    NOTES RECEIVABLE (Continued)

shares of  common  stock of the  Company.  The  Company  performed  analysis  to
determine  if  Nature's  Own is  required  to be  consolidated  under  ASC  810,
Consolidations,  and determined that the Company is not the primary beneficiary.
As a result, consolidation was not required.

The balance of the note receivable as of December 31, 2014, was $965,000.
Accrued interest receivable for the period ended December 31, 2014 was $16,909.
Interest income for the three month period ended December 31, 2014 was $45,206.

Effective  January 1, 2015 the Company and Natures' Own Wellness Center modified
the loan agreement and consulting  agreement (Note 10) between the parties.  The
modification to the loan agreement  eliminated  required  principal payments for
January  through  May 2015 and  increased  the final  principal  payment  due on
December 1, 2016 to $182,531.  The  consulting  agreement was modified to extend
the  term of the  consulting  agreement  to May  31,  2017.  Monthly  consulting
payments of $10,000 remain the same.

NOTE 4.    DEPOSITS

The Company has entered into Letters of Intent with two groups that are applying
for cannabis cultivation licenses as a part of the Illinois Compassionate Use of
Medical Cannabis Pilot Program Act.

As part of this  agreement,  Americann,  Inc.  deposited  $100,000  into a Trust
Account held by its corporate  attorneys as deposits for two Loan Agreements for
applications  in  the  Illinois  medical  marijuana  program.  As per  the  Loan
Agreements,  AmeriCann,  Inc. deposited $50,000 into a trust account for each of
the  applications.  The loan  agreements  will only  become  effective  when the
applications  are  approved and if the  applications  are not approved the funds
will be returned to Americann.

Under the terms of the agreements,  in addition to consulting,  AmeriCann,  Inc.
may  provide  capital  for  the   acquisition  of  land,   working  capital  and
construction for new cannabis  cultivation  facilities in the state of Illinois.
If all  licenses  are  granted  to  these  applicants  in  Illinois,  the  total
investment could exceed $9,000,000.

If neither of the  licenses are  granted,  none of the parties to the  agreement
will have any financial  obligation to one another.  Additionally,  in the event
that  one or two  licenses  are  granted  by the  State  of  Illinois  to  these
applicants, AmeriCann, Inc. will have no financial obligation to provide capital
or any other  obligations.  However,  in the event that either of the applicants
are granted  licenses  and these  license  recipients  then refuse to accept the
loans and consulting services of AmeriCann,  the agreements call for the license
recipients to pay a breakup fee to AmeriCann,

                                       11
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 4.    DEPOSITS (Continued)

Inc. The agreements call for breakup fees to be paid to AmeriCann in the amounts
of  $1,292,400  and  $1,230,000  for the  various  agreements  respectively,  or
$2,522,4000 in aggregate for both agreements to be paid over 24 months.

On February 2, 2015 WGP was notified that it was awarded one of the licenses for
which it had applied.  It was not awarded a second  license.  Under the terms of
the loan agreement  pertaining to the license awarded to WGP, the Company agreed
to loan WGP up to $4,700,000,  subject to certain conditions.  Proceeds from the
loan would be used to  construct  the  marijuana  cultivation  facility  and for
start-up costs.

The  loan  agreement  also  provided  that,   within  seven  days  of  receiving
notification that a license  application has been accepted,  WGP was required to
notify the Company of its election to proceed to close the loan.  If WGP did not
notify the Company of its election to proceed to close the loan within the seven
day period,  WGP agreed to pay the Company a breakup  fee of  $150,000,  payable
upon the  expiration  of the  seven  day  period,  plus  $47,600  per  month for
twenty-four months.

On February 9, 2015 WGP  notified  the Company that it would not close the loan.
Accordingly,  the  Company  intends to notify WGP of its  obligation  to pay the
breakup fee.

The $100,000 deposited into a trust account will be returned to the Company.

NOTE 5.   EARNINGS PER SHARE

The following  table sets forth the  computation of basic and diluted net income
per share:

                                                          For the three months
                                                           Ended December 31,
                                                          2014            2013
                                                          ----            ----

Net (loss) income attributable to common
 stockholders                                         $(242,003)        $(5,700)

Basic weighted average outstanding shares of
 common stock                                        16,581,000      16,100,000

Dilutive effects of common share equivalents                 --              --

Dilutive weighted average outstanding shares of
 common stock                                        16,581,000      16,100,000
                                                    ===========      ==========

Net loss per share of voting and nonvoting
 common stock
 Basic and Diluted                                  $    (0.01)     $    (0.00)
                                                    ==========      ==========

                                       12
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 6.  INCOME TAXES

We recorded no income tax  expense or benefit for the three month  period  ended
December 31, 2014.  We increased  our  valuation  allowance  and reduced our net
deferred tax assets to zero. Our  assessment of the  realization of our deferred
tax assets  has not  changed,  and as a result we  continue  to  maintain a full
valuation allowance for our net deferred assets as of December 31, 2014.

As of December 31, 2014, we have no  unrecognized  tax  benefits.  There were no
significant changes to the calculation since December 31, 2013.

NOTE 7. STOCK BASED COMPENSATION

On March 25, 2014,  the Company  entered into an employment  agreement  with Mr.
Keogh. The agreement: (i) has an initial term of three years; (ii) requires that
Mr.  Keogh devote at least 50% of his time to the Company  and;  (iii)  provides
that the Company  will pay Mr.  Keogh  $12,000 per month  during the term of the
agreement.  Pursuant to the employment  agreement,  Strategic  Capital Partners,
LLC, the Company's largest  shareholder,  sold 1,200,000 shares of the Company's
common stock to Mr.  Keogh at a price of $0.001 per share.  The  estimated  fair
market  value of the  stock was $.75 per share  based the then  current  Private
Placement Memorandum in place resulting in an aggregate stock based compensation
of approximately  $900,000 for the difference  between the estimated fair market
value of $.75 and the purchase price of $.001 per share.  As the Company expects
the shares to be earned over the vesting  period,  the Company will amortize the
entire  amount  to  stock  based  compensation  in the  Company's  statement  of
operations  over the vesting  period.  For the three month period ended December
31,  2014,  the  Company  has  amortized  approximately  $102,000 to stock based
compensation. Through December 31, 2014, the Company has amortized approximately
$533,000.

NOTE 8.    RELATED PARTY TRANSACTIONS AND RELATED PARTY NOTES PAYABLE

During year ended  September  30, 2014,  the  President of the Company  advanced
approximately  $16,000 to cover certain  expenses.  Of this amount,  $10,500 was
repaid  prior to  September  30,  2014.  This cash  advance  is  evidenced  by a
non-interest  bearing note, is due on demand and is recorded under related party
payables in the accompanying  balance sheet. The outstanding  balance was $5,500
as of September 30 and December 31, 2014, respectively.

On October 6, 2014,  the  Company  made a payment of $50,000 on the  outstanding
balance of the loan to Strategic  Capital  Partners.  On December 16, 2014,  the

                                       13
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 8.    RELATED PARTY TRANSACTIONS AND RELATED PARTY NOTES
           PAYABLE (Continued)

Company  received an additional  $30,000 from Strategic  Capital  Partners.  The
total  outstanding  loan balance was  $805,000 at December  31,  2014,  which is
recorded under note payable related party in the accompanying balance sheet. The
loan  accrues  interest at a rate of 5% per annum.  The loan is due December 31,
2015.  Interest only payments and principal can be prepaid at the  discretion of
the Company's  management.  The balance of accrued interest at December 31, 2014
and September 30, 2014,  respectively was $15,053 and $5,192.  Interest payments
were $0 for the three month period ended December 31, 2014.

Interest expense related to the related party note payable was $9,862 and $-0-
for the three month period ended December 31, 2014 and 2013, respectively.

At times Strategic  Capital Partners will pay expenses on behalf of the Company.
During the three  month  period  ended  December  31,  2014,  Strategic  Capital
Partners paid expenses of $37,720 on behalf of the Company. Total amounts due to
Strategic Capital Partners related to these expenses was $37,720 at December 31,
2014.

NOTE 9.    OPTIONS AND WARRANTS

Options

No options  were issued  during the three months  ended  December 31, 2014.  The
Company  recognized  stock option  expense of  approximately  $10,000 during the
three month period ended December 31, 2014.

Stock option activity is presented below.
                                                          Weighted
                                              Weighted     Average
                                               Average   Contractual  Aggregate
                                  Number of   Expected      Term      Intrinsic
                                    Shares      Price     (Years)       Value
                               ------------------------------------------------

Outstanding at September 30, 2014  1,105,000  $ 26.49          --          --
                                   ---------            ---------   ---------
Outstanding at December 31, 2014   1,105,000  $ 26.49           2          --
                                   =========  =======   =========   =========
Expected to vest at after
December 31, 2014                  1,080,000  $26.49           --          --
                                   =========  ======    =========   =========
Exercisable at December 31, 2014      25,000    0.75           --          --
                                   =========  ======    =========   ==========

Total  remainder  of stock  compensation  expense to be  recognized  through the
vesting  date of the above  options as of December 31, 2014 is  approximately
$ 65,000.

                                       14
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
                      Notes To Unaudited Condensed Financial Statements For the
                three month period ended December 31, 2014 and 2013

NOTE 9.    OPTIONS AND WARRANTS (Continued)
Warrants

There were no grants of warrants  during the three  months  ended  December  31,
2014.  There was no stock based  compensation  expense  related to the  warrants
during the three months ended December 31, 2014.

The  following  table  shows the warrant  activity  for the three  months  ended
December 31, 2014:

                                                           Weighted
                                   Shares     Weighted      Average     Weighted
                                   Issuable   Average      Remaining    Average
                                     Upon     Exercise      Contract   Intrinsic
                                   Exercise      Price     Term (yrs)    Value
                                   --------  ------------  ----------  ---------
Outstanding - September 30, 2014
                                  2,591,000     $3.00         1.4           --

  Granted                                          --
  Exercised                              --        --         --
  Cancelled

Outstanding - December 31, 2014   2,591,000     $8.92        3.7        $   --
                                  ---------     -----     ------        ======

Exercisable - December 31, 2014   2,591,000     $8.92        3.7        $   --
                                  =========     =====     ======        =======

There was no stock based  compensation  expense  during the three  months  ended
December 31, 2014.

There were no grants of warrants  during the three  months  ended  December  31,
2014.

NOTE 10. COMMITMENTS AND CONTIGENTCY

In connection with the note receivable from Nature's Own Wellness Center,  Inc.,
on July 1, 2014, the Company  entered into a consulting  agreement with Nature's
Own Wellness Center, Inc. The Company will provide general advisory services for
business development, facilities design and construction, cultivation and retail
operations,  marketing and the improvement and expansion of existing operations.
The Company receives monthly compensation of $10,000 plus pre-approved expenses.
The  consulting  agreement  terminates  on December  31,  2016.  The Company may
terminate  the agreement  without  cause with a 30 day notice.  Nature's Own may
terminate the agreement if the Company does not provide  funding as specified in

                                       15
<PAGE>

                                 AMERICANN, INC.
                         (fka NEVADA HEALTH SCAN, INC.)
            Notes To Unaudited Condensed Financial Statements For the
               three month period ended December 31, 2014 and 2013

NOTE 10. COMMITMENTS AND CONTIGENTCY (Continued)

the agreement or if the Company does not or is unable to perform its duties. The
consulting agreement was modified to extend the term of the consulting agreement
to May 31, 2017. Monthly consulting  payments of $10,000 remain the same.For the
three month period ended  December  31,  2014,  the Company  earned and received
$30,000 for consulting services.

NOTE 11. LEASE COMMITMENTS

The Company leases its office space located at 3200 Brighton Boulevard,  Denver,
Colorado for $2,710 per month commencing June 18, 2014 and ending June 30, 2015.
The Company  paid a  refundable  deposit of $3,110.  Rent  expense for the three
month period ended December 31, 2014 and 2013 was approximately  $8,310 and $-0-
respectively.

The Company leases an automobile under an operating lease commencing  October 4,
2014 for 39 months at $611 per  month.  The lease  expense  for the three  month
period  ended  December 31, 2014 and 2013 was $2,458 and $-0-  respectively.  At
December 31, 2014 the future rental payments required under operating leases are
$21,386

NOTE 12.    SUBSEQUENT EVENTS

In January  and  February  of 2015 the Company  received  $760,000 in  principal
increasing the note payable to a related party to a balance of $1,565,000.

On January 14,  2015,  the Company  entered into an agreement to purchase a 52.6
acre parcel of  undeveloped  land in  Freetown,  Massachusetts.  The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the

                                       16
<PAGE>

MMCC may include the  construction  of sustainable  greenhouse  cultivation  and
processing  facilities  that  will be  leased  or sold to  Registered  Marijuana
Dispensaries under the Massachusetts Medical Marijuana Program. Additional plans
for the MMCC may include a testing laboratory,  a research facility,  a training
center, an infused product production facility and corporate offices.

The Company  paid the seller a refundable  $100,000  deposit upon the signing of
the  agreement  which  amount  will be  applied  toward  the  purchase  price of
$4,000,000 at the closing or returned at the option of the Company.  The closing
must take place on or before June 1, 2015.

                                       17
<PAGE>

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operation

BUSINESS AND PLAN OF OPERATION

We were  incorporated  on June 25,  2010  under  the laws of  Delaware.  We were
established as part of the Chapter 11 reorganization  of AP Corporate  Services,
Inc.  ("AP").  Under  AP's  Plan of  Reorganization,  as  confirmed  by the U.S.
Bankruptcy  Court for the Central District of California,  we were  incorporated
to:  (i) hold  any  interest  which AP  retained  in the  development  of an MRI
facility in Nevada;  and (ii) issue  shares of its common  stock to AP's general
unsecured creditors, to its administrative creditors, and to its shareholders in
order to enhance their opportunity to recover from the bankruptcy estate.

Since we lacked the  resources to  effectively  develop an MRI facility in June,
2012,  we decided to promote  medical  tourism  by  providing  information  on a
website for those seeking to travel abroad for healthcare  services.  We planned
to generate revenue by selling  advertising to healthcare  providers and related
businesses including hotels and travel businesses.

In September  2013 we abandoned our business plan relating to promoting  medical
tourism.

Our new business  plan  involves  providing an essential  set of services to the
regulated  cannabis  industry.  The market research firm ArcView Group estimates
the market  for the  regulated  cannabis  industry  for 2013 was $1.53  billion,
expected to grow to $2.53 billion in 2014 and $10.2 billion in ten years.  Based
on the ArcView analysis,  the cannabis industry is projected to grow faster than
any other industry in the country over the next decade.

While the industry is growing  rapidly,  the cannabis  industry  faces two major
obstacles  that  challenge  its growth and  profitability.  The  cultivation  of
cannabis is a very capital-intensive  enterprise. Many cannabis entrepreneurs do
not have access to the capital that is necessary to build the  infrastructure to
meet growing demand.  Traditional  sources of financing,  such as banks, are not
available  currently  to cannabis  producers  and  retailers.  Also,  there is a
significant shortage of knowledge related to virtually all areas of the cannabis
business.  When new states are added to the list of regulated  cannabis markets,
there will be a  scarcity  of  experience  and  expertise  to serve the needs of
growers and retailers in these states.

We believe that, since the industry is so new, there is significant potential to
transform the cannabis  business  through  professionalism,  innovation  and the
application of technology.

We are  based in  Colorado,  which by  virtue  of it being  the  first  state to
implement cannabis access to adults for non-medical purposes,  provides an ideal
environment  for which to serve the  growing  cannabis  industry  as it  expands
nationally.

We do not intend to cultivate, produce, distribute or sell cannabis, but plan to
provide a wide variety of essential  services to  licensed,  regulated  cannabis
growers and retailers.  These services  include  financing,  cultivation  center
design, operational consulting, real estate development, and research.

                                       18
<PAGE>

We  plan  to  generate  revenue  and  profits  from  several  sources  including
developing and selling  cannabis  cultivation  facilities,  interest income from
loans to licensed  cannabis  operators,  consulting and the licensing or sale of
intellectual property.

In January 2014, we began operating in accordance with our new business plan.

On January 17, 2014,  Strategic Capital Partners,  LLC ("SCP") a firm controlled
by Benjamin J. Barton,  acquired  14,950,000  shares of our  outstanding  common
stock from a group of our shareholders.

On  February  21,  2014 we changed our name from  Nevada  Health  Scan,  Inc. to
Americann,  Inc. and  declared a stock  dividend in the amount of four shares of
common stock for each issued and outstanding share of common stock.

On February 24, 2014 SCP returned 65,750,000 of its shares to us.

During  March and April 2014 we sold  1,000,000  shares of our  common  stock to
private investors at a price of $0.75 per share.  Benjamin J. Barton, one of our
officers and directors, purchased 400,000 shares as an investment.

During the summer of 2014 we entered into a Financing and  Consulting  Agreement
with Nature's Own Wellness  Centers,  a licensed  Colorado  cannabis  dispensary
owner and grower.  Pursuant to the agreement, we loaned Nature's Own $1,000,000.
The  proceeds  of the secured  loan will be used by  Nature's  Own to convert an
existing 15,000 square foot warehouse into a new cannabis growing and processing
facility.

During July 2014 we raised $2,373,000 through a private sale of 791,000 Units at
a price of $3.00 per Unit.  Each Unit consisted of one share of common stock and
one warrant.  Each warrant allows the holder to purchase one share of our common
stock at a price of $8.00  per  share  anytime  on or  before  April  30,  2018.
Benjamin J. Barton purchased 666,667 Units for cash as an investment.

The loan has a 30-month  term,  bears  interest at 18%  annually,  and  requires
monthly  payments to us.  Nature's  Own will also pay us $300,000 in  consulting
fees for its cannabis  operations over the 30-month period. Over the term of the
30-month loan, the agreement calls for us to receive average monthly payments of
principal, interest and consulting fees in excess of $56,000.

Effective  January 1, 2015 we modified our loan and  consulting  agreement  with
Natures  Own.  The  modification  to  the  loan  agreement  eliminated  required
principal  payments  for  January  through  May 2015  and  increased  the  final
principal payment due on December 1, 2016 to $182,531.  The consulting agreement
was  modified to extend the term of the  consulting  agreement by five months to
May 31, 2017. Monthly consulting payments of $10,000 remain the same.

On July 31, 2014 we closed on an all cash purchase of a five-acre parcel of land
located in north central  Denver,  Colorado.  The total  purchase  price for the
property was  $2,250,000.  We plan to develop the property as a facility  called
the "Denver  Cannabis  Center."  The  property is  currently  zoned for cannabis
cultivation and processing by the City and County of Denver.

                                       19
<PAGE>

The Denver  Cannabis  Center will be designed to include  125,000 square feet of
greenhouse and indoor cultivation areas. We plan to sell these facilities to one
or more  licensed  cannabis  entrepreneurs.  Additional  plans  for  the  Denver
Cannabis Center include a dispensary, a research facility, a training center, an
infused product production facility and corporate offices.

In developing the Denver Cannabis Center, we plan to use the most innovative and
advanced cultivation methods available. We believe that through effective design
and optimal practices,  its clients and partners can achieve greater efficiency,
product quality and the highest level of environmental standards.

We plan to build the Denver project as a prototype for development of comparable
facilities in other states that allow for and regulate cannabis. To complete the
project as planned,  the Company will need to receive all  necessary  government
approvals as well as additional capital.

On September 21, 2014 we entered into two loan  agreements  with Wellness  Group
Pharms,  LLC  ("WGP").  Subsequent  to entering  into the loan  agreements  WGP,
applied  to the  state  of  Illinois  for  licenses  to  operate  two  marijuana
cultivation facilities.

On February 2, 2015 WGP was notified that it was awarded one of the licenses for
which it had applied.  It was not awarded a second  license.  Under the terms of
the loan agreement  pertaining to the license  awarded to WGP, we agreed to loan
WGP up to  $4,700,000,  subject to certain  conditions.  Proceeds  from the loan
would be used to construct the marijuana  cultivation  facility and for start-up
costs.

The  loan  agreement  also  provided  that,   within  seven  days  of  receiving
notification that a license  application has been accepted,  WGP was required to
notify us of its election to proceed to close the loan. If WGP did not notify us
of its  election to proceed to close the loan  within the seven day period,  WGP
agreed to pay us a breakup fee of $150,000,  payable upon the  expiration of the
seven day period, plus $47,600 per month for twenty-four months.

On  February  9,  2015,  WGP  notified  us that it would  not  close  the  loan.
Accordingly, we notified WGP of its obligation to pay us the breakup fee.

On January 14, 2015, we entered into an agreement to purchase a 52.6 acre parcel
of  undeveloped  land  in  Freetown,  Massachusetts.  The  property  is  located
approximately  47 miles southeast of Boston.  We plan to develop the property as
the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC may include
the construction of sustainable greenhouse cultivation and processing facilities
that will be  leased  or sold to  Registered  Marijuana  Dispensaries  under the
Massachusetts  Medical  Marijuana  Program.  Additional  plans  for the MMCC may
include a testing laboratory, a research facility, a training center, an infused
product production facility and corporate offices.

We paid the seller  $100,000 upon the signing of the agreement which amount will
be applied toward the purchase  price of $4,000,000 at the closing.  The closing
must take place on or before June 1, 2015.

We  plan to  expand  to  other  states  that  have  approved  and  regulate  the
cultivation and sale of cannabis.

                                       20
<PAGE>

RESULTS OF OPERATIONS

During the three month  period ended  December 31, 2014 we generated  $30,000 in
revenue and $45,206 in interest  income,  however for December 31, 2013, we have
generated  no revenue.  As a result we have no  operating  history upon which to
evaluate our intended business.

Operating  expenses,  which  consisted  solely  of  general  and  administrative
expenses for the three month period ended December 31, 2014, were $307,347. This
compares with  operating  expenses for the three month period ended December 31,
2013 of $5,700.  The major  components  of general and  administrative  expenses
include  accounting fees,  contract and consulting fees,  legal,  salaries,  and
stock based compensation.

As a result of the foregoing,  we had a net loss of $242,003 for the three month
period  ended  December 31, 2014.  This  compares  with a net loss for the three
month period ended December 31, 2013 of $5,700.

Salaries were $30,518 for the three month period ended December 31, 2014.

Since the Company was inactive prior to January 2014, any comparison of the
Company's operating results for the three months ended December 31, 2014 and its
financial condition as of December 31, 2014 with any prior periods would not be
meaningful.

LIQUIDITY AND CAPITAL RESOURCES

As of February  10,  2015 we had  borrowed  $1,565,000  from  Strategic  Capital
Partners, LLC, a Company controlled by Benjamin J. Barton. The loan is unsecured
and bears interest at 5% per year. Interest is payable on March 31 and September
30 of each  year.  The  loan,  plus all  unpaid  principal  interest,  is due on
December 31, 2015.

The  Company's  sources and (uses) of funds for the three months ended  December
31, 2014 are shown below:

Net cash provided by (used in)  operations      $(115,687)
Loan payments from third party                    $35,000
Stock based compensation and option expense      $112,784
Loan from related party                           $30,000
Payments to related party                        $(50,000)

The  Company  does not have any firm  commitments  from any person to provide it
with any capital.

See Item 7 of our  10-K  report  for the year  ended  September  30,  2014 for a
discussion of the Company's critical accounting policies.

As of  December  31,  2014  the  Company  did not  have  any off  balance  sheet
arrangements.

Item 4.  Controls and Procedures.

(a) The Company maintains a system of controls and procedures designed to ensure

                                       21
<PAGE>

that  information  required to be disclosed in reports filed or submitted  under
the  Securities  Exchange Act of 1934,  as amended  ("1934  Act"),  is recorded,
processed,  summarized and reported,  within time periods specified in the SEC's
rules and forms and to ensure that  information  required to be disclosed by the
Company  in the  reports  that it files  or  submits  under  the  1934  Act,  is
accumulated  and  communicated  to  the  Company's  management,   including  its
Principal  Executive  and Financial  Officers,  as  appropriate  to allow timely
decisions regarding required disclosure.  As of December 31, 2014, the Company's
Principal  Executive and Financial  Officers  evaluated the effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on that evaluation,  the Principal  Executive and Financial  Officers  concluded
that the Company's disclosure controls and procedures were not effective.

(b)  Changes in  Internal  Controls.  There  were no  changes  in the  Company's
internal control over financial  reporting during the quarter ended December 31,
2014, that materially  affected,  or are reasonably likely to materially affect,
its internal control over financial reporting.

                           PART II. OTHER INFORMATION

Item 6.  Exhibits

Exhibits

31.1    Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2    Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32      Certification pursuant to Section 906 of the Sarbanes-Oxley Act.


                                       22
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                      AMERICANN, INC.


February 23, 2015                      By:/s/ Timothy Keogh
                                          ------------------------------
                                          Timothy Keogh, Principal Executive
                                          Officer





February 23, 2015                      By:/s/ Benjamin J. Barton
                                          ------------------------------
                                          Benjamin Barton, Principal Financial
                                          and Accounting Officer

                                       23
<PAGE>